METiS Therapeutics
Cambridge
About METiS Therapeutics
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $176.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2022)
- Website: metistx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/metis-therapeutics-58500 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.